Inventor · disambiguated record
Dauntel S. Verwijs
Also filed as: VERWIJS DAUNTEL S
2 granted patents·6 pending applications·7 citations·filing 2010–2023
55Inventor score
Top patents by PatentIndex Score
8 records- 0178US2024082275A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0277US9504693B2Pharmaceutical compositions for the treatment of cancer and other diseases or disordersMILLENNIUM PHARM INC·Filed 2015·Granted Nov 29, 2016·3 cites·20 claims
- 0376US9127011B2Pharmaceutical compositions for the treatment of cancer and other diseases or disordersMILLENNIUM PHARM INC·Filed 2013·Granted Sep 8, 2015·4 cites·17 claims
- 0471US2022249524A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 0569US2021401860A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 0666US2021186994A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 0755US2018256610A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2018·Application pending·0 cites
- 0844US2011039826A1Pharmaceutical compositions for the treatment of cancer and other diseases or disordersMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →